TRO endeavours to support our academics drive change for those living with a rare disease

Today (28 February 2023) is Rare Disease Day, and here at UCL and our partner hospitals, we have over 100 clinical academic research groups investigating more than 350 rare diseases. To mark this meaningful day, we are delighted to share with you a snapshot of the Translational Research Office’s (TRO) endeavours to support our academics drive change for those living with a rare disease.

• We secured a LifeArc Pathfinder award of £500K to support early-stage translational projects looking to diagnose and treat rare diseases.
• We launched the UCL Therapeutic Acceleration Support (TAS) rare disease call and received 19 applications. Results will be announced soon, and we are ready to support the awardees to advance rare disease research.
• The late-stage rare disease portfolio managed via the TRO has substantially grown in the past 10 years, spanning a wide range of disease areas and attracting £90m of public funds – see the banner image and below. 

Interested to stay informed of upcoming events alike?

• Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations
• Follow us on social media (LinkedIn, Twitter) and stay tuned to our news and updates.

TRO has created an online, internal portal (UCL sign-in required) to showcase the breadth of biomedical expertise at UCL and our partner hospitals, aiming to facilitate multidisciplinary collaborations and capabilities mapping. 

• Input your profile to get your capabilities visible across UCL experts and potentially external partners facilitated by TRO, leading to collaboration and funding opportunities.